期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

前列腺癌的放射治疗 被引量：1

下载PDF
导出
摘要 一、概况 前列腺癌是老年男性的常见肿瘤,通常认为欧美地区的白人和黑人好发此病.国内男性的发病率较低,但近十年来国内男性的发病率有明显上升的趋势.由于前列腺癌好发于老年人,常常因各种原因而不能进行根治性前列腺手术切除治疗,因此放射治疗成为主要的局部治疗手段.
作者 王国民
机构地区 复旦大学附属华东医院放射治疗科
出处 《老年医学与保健》 CAS 2007年第3期188-190,共3页 Geriatrics & Health Care
关键词 前列腺癌 放射治疗 老年男性 手术切除治疗 欧美地区 局部治疗 发病率 老年人
分类号 R737.25 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1Aref I,Eapen L,Agboola O,et al.The relationship between biochemical failure and time to nadir in patients treated witw extermal beamtherapy for T1-T3 prostate carcinoma.Radiother Oncol,1998,48:203～207.
  • 2Pollack A,Smith LG,Von Eschenbach AC.External beam radiotherapy dose response characteristics of 1127 men with prostate carcinoma treated in the PSA era.Int J Radiat Oncol Biol Phys,2000,48:507～512.
  • 3Sandler HM,Dunn RL,Mclaughlin PW,et al.Overall survival after prostate-specific-detected recurrence following conformal radiation therapy.Int J Radial Oncol Biol Phys,2000,48:629～633.
  • 4Shrader-Bogen CI,Kjellberg JL,Mcpherson CP,et al.Quality of life and treatment outcomes:prostate carcinoma patients perspectives after prostatectomy or radiation therapy.Carcinoma,1997,79:1977～1986.
  • 5Pickles T.Prostate-specific antigen(PSA) bounce and other fluctuations:Which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy.Int J Radiat Oncol Biol Phys,2006,64:1355～1359.
  • 6Ronson BB,Yonemoto LT,Rossi CJ,et al.Patient tolerance of rectal balonnns in conformal radiation treatment of prostate cancer.Int J Radiat Oncol Biol Phys,2006,64:1367～1370.
  • 7Ray ME,Thames HD,Levy AA,et al.PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer.A multi-institutional analysis.Int J Radiat Oncol Biol Phys,2006,64:1140～1150.
  • 8Lawton CA,DeSilvio M,Lee WR,et al.Results of a phase Ⅱtrail of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate(radiation therapy Oncology group 98-05).Int J Radiat Oncol Biol Phys,2007,67; 39～47.
  • 9Sylvester JE,Grimm PD,Blasko JC,et al.15-year biochemical relapse free survival in clinical stage T1-T3 prostate cancer following combined external beam radiotherapy:Seattle Experiemce.Int J Radiat Oncol Biol Phys,2007,67:39～47.
  • 10Mould RF.Robotic Radiosurgery.The CyberKnife Society Press Sunnyvale.California,2007,315～324.

同被引文献21

  • 1唐鑫.前列腺癌的放射治疗[J].临床军医杂志,2007,35(1):107-111. 被引量：16
  • 2Horwilz E M. Why external beam radiotherapy is lrealment of choice for most men with early stage non metastatic prostate cancer[J]. Urology, 2008.19[Epub ahead of print].
  • 3Li X A, Wang J Z, Jursinie P A, et al. Dosimetrie ad vantages of IM RT simultaneous integrated boost for high ·- risk prostate can-ce[J]. Int J Radial Oncol Biol Phy, 2005, 61(4):1251- 1257.
  • 4Zelelsky M J, Yoshiya Y, Kollmeier M A,etal. Long- term outcome following three dimensional conformal/ intensity modulated external beam radiotherapy for clinical stage T3 prostate cancer[J]. European Urology, 2008, 53(6): 1172-1179.
  • 5Zelefsky M J, Michael W. Ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer [J]. Adult Urology, 2007, 70(2): 283-287.
  • 6Goldner G. Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose(66 Gy) [J]. Strahlenther Onkol, 2006, 9: 537-542.
  • 7Michalski J M, Winter K, Purdy J A, et al. Toxicity after three2di2 men2sional radiotherapy for p rostate cancer with RTOG 9406 dose level Ⅳ[J]. Int J Radiat Oncol Biol Phys, 2004, 58: 735-742.
  • 8Mohan R, Zhang X, Wang H, et al, Use of deformed intensity distributions for on21ine modification of image2guided IMRT to account for interfractional anatom changes[J]. Int J Radiat On2 col Biol Phys, 2005,61 :1258-1266.
  • 9Pollack, Alan S, Lewis G,et al. External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era[J]. International Journal of Radiation Oncology Biology Physics, 2000, 48(2) : 507-512.
  • 10Michel B. Clinical stage T3 prostate cancer: the added value of three-dimensional conformal/Intensity-modulated external-beam radiotherapy[J]. Eur Urol, 2008, 53:1104-1106. European Urology, 2008, 53(6) : 1106 -1108.

引证文献1

二级引证文献1

老年医学与保健
2007年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部